Newave Pharmaceutical Inc.
Records under this name other than the patents Newave Pharmaceutical Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Showing 1 to 3 of 3 · Back to Newave Pharmaceutical Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,236,089 | Substituted pyrrolopyridines as ATR inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,456,397 | Covalent inhibitors of CDK-7 Lapsed on the fee record Ended Oct 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2023 | From the USPTO record |
| US 10,195,200 | Covalent inhibitors of CDK-7 Lapsed on the fee record Ended Feb 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2023 | From the USPTO record |